ESTRELLA IMMUNOPHARMA INC (ESLA) Stock Cash Flow
NASDAQ:ESLA - Nasdaq - US2975841048 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2024 (2024-6-30) | 2023 (2022-12-31) | 2022 (2021-12-31) | 2021 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.68M | -7.31M | -1.00M | -250.00K | -250.00K | |||
| Income Taxes - Deferred | N/A | N/A | 30.00K | 30.00K | N/A | |||
| Change In Working Capital | -9.19M | -9.95M | 580.00K | -70.00K | -70.00K | |||
| Interest Paid | N/A | 2.66K | 0.00 | 0.00 | N/A | |||
| Taxes Paid | N/A | 1.60K | 0.00 | 0.00 | N/A | |||
| Other non cash items | 0.00 | 1.19M | -650.00K | 0.00 | 0.00 | |||
| OPERATING CASH FLOW | -18.01M | -16.07M | -1.04M | -320.00K | -320.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | 5.07M | 4.96M | 36.17M | -45.19M | -45.19M | |||
| INVESTING CASH FLOW | 5.07M | 4.96M | 36.17M | -45.19M | -45.19M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 50.00K | 50.00K | N/A | |||
| Stock Issued/Repurchased | -504.91K | 8.67M | -36.11M | 47.45M | 47.45M | |||
| Other Financing Activity | -6.60M | 4.13M | 500.00K | -1.47M | -1.47M | |||
| FINANCING CASH FLOW | -7.40M | 12.79M | -35.56M | 45.98M | 45.98M | |||
| CHANGE IN CASH | -20.34M | 1.69M | -430.00K | 470.00K | 470.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.01M | -16.07M | -1.04M | -320.00K | -320.00K | |||
| FREE CASH FLOW | -18.01M | -16.07M | -1.04M | -320.00K | -320.00K | |||
All data in USD